Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with rheumatoid arthritis (a condition where the immune system attacks the joints) based on recognised medical guidelines
- You have had this diagnosis for more than 2 years
- Your rheumatoid arthritis is moderately active, based on a specific disease activity score (called DAS28) that your doctor can measure — the score must be below 5.1
- You are willing to take part in the study voluntarily
- You have lung problems that are related to your condition
Who may not be able to join:
- You have bone or joint deformities that could interfere with the treatment involved in the trial
- You are pregnant
- You have diabetes or a heart condition that is not well controlled
- You have taken part in a rehabilitation programme (such as physiotherapy or exercise therapy) in the last 6 months
- Your Body Mass Index (BMI), which is a measure of body weight relative to height, is over 30
- You have serious failure of a major organ, such as the kidneys or liver (confirm with trial site)
- You have recently had a heart attack or a related serious heart event (confirm with trial site)
- You currently have an active infection of any kind
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Esra PEHLİVAN, Assoc. Prof., Saglik Bilimleri Universitesi
Phone: +90 216 346 36 36
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
lncRNA HOTAIR expression levels; Short Form - 36; Respiratory Muscle Strength Measurement; Visual Analog Scale (VAS); Exercise capacity (6-minute walk test)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.